Pharmafile Logo

Live Webinar: China in the fast lane: How to play and win in the world’s hottest emerging market

April 9, 2019 | China, Pharma, webinar 

Tuesday 16th April 2019 10:00 EST/ 15:00 GMT / 16:00 CEST

China has always been believed to be the land of promise for multinational pharmaceutical companies. However, up until recently many organisations have struggled to see a return on their investments. That may all be set to change though.

The country’s recent 2020 healthcare reforms aim to rapidly increase the pace of new drug approvals and fast track innovative treatments, opening up a whole new world of opportunities for the pharmaceutical industry.

Register now for our next live webinar in which emerging markets experts Marc Yates and Helen Ansell will explore China’s evolving healthcare environment, highlight the key changes affecting pharma and show you how to  build the market understanding required to launch a brand effectively in this exciting region.

When: Tuesday 16th April 2019 
Time: 10:00 EST/ 15:00 GMT / 16:00 CEST

Register now to secure your place »

China’s key growth factors:

Fast track approvals: So far, over 180 foreign pharma products have been granted priority review and will likely hit the market within the next few years.

From an ability to pay to willingness to pay: By 2022 more than half of the urban population will be defined as upper middle class and as incomes rise so does willingness to pay for quality healthcare.

Shifting disease patterns: Diseases of affluence are also on the rise and the benefits of urban life have resulted in an aging population and an explosion in age-related conditions.

What are the key takeaways in this webinar? 

1. China 101 
An overview of the healthcare environment in China

2. What’s changed?
The key opportunities under China’s 2020 healthcare reform

3. Where to play? How to win?
Design an effective marketing strategy with insights that prepare you for optimal success.

4. Gain answers to your key questions
Start the conversation by submitting your questions in advance when you register.

Register now to secure your place »
If you are unable to attend but would like to view the recording, register now and we will send you a unique link to download it as soon as it is ready.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Webinar: Uncovering hidden insights into patient compliance

Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment...

Webinar: The patient journey: Time to look beyond the physician?

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

Webinar: Ensuring an actionable segmentation

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.

Webcast: Leveraging the ASEAN opportunities

Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.

Webcast: Biosimilars: Friend or Foe to Healthcare?

Understanding the opportunities for biosimilars and the threats to innovator biologics

Webinar: Understanding the patient journey in China

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers...

Webinar: Capturing “in-the-moment” patient and physician insights

Utilising the benefits of mobile technology

Webinar: Observational Research

Presenting a window on the world of your customer

Webinar: The Brazil Conundrum

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...